Situation of Pediatric Radiotherapy in Morocco: First National Survey

##plugins.themes.academic_pro.article.sidebar##

Published Nov 24, 2023
Download
pdf
Vol. 101 No. 11 (2023): Tunis Med nov

##plugins.themes.academic_pro.article.main##

Nabiha Sellal
Department of Radiotherapy, Mohamed VI University Hospital of Tangier, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaadi University, Morocco
Souha Sahraoui
Mohammed VI Center for Cancer Treatment, CHU Ibn Rochd, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Morocco
Mohamed El Hfid
Department of Radiotherapy, Mohamed VI hospital university of Tangier, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaadi University, Morocco

Abstract

Background: Pediatric radiotherapy (PR) faces several issues in middle- and low-income countries.


Aim: Our study is a cross-sectional observation which aimed to describe the current situation of PR in Morocco in order to identify the needs and to propose an organizational shema for this discipline.


Methods: The collection of data used two surveys, one of which was intended to the heads of the radiotherapy department of all university hospital centers (UHC) in Morocco concerning the hospital's infrastructure, human resources, technical and the course of radiotherapy. A second survey was intended for all radiation oncologists trained and working in Morocco with data related to the practice of PR.


Results: In 2021, 295 children were treated in the radiotherapy departments of the seven university hospitals in Morocco. One hundred and two radiation oncologists responded to our survey. The multidisciplinary consultation board is held in five university hospitals, four of which have a complete multidisciplinary team. The children are sent to another structure by default of anesthesia according to 21% of the radiotherapists questioned. The three-dimensional technique is available in all university hospitals. Intensity modulated radiotherapy is available in 5 UHC. Additional training in radiotherapy after residency was necessary according to 60% of the radiotherapists questioned.


Conclusion: Despite the progress that Morocco has made in terms of infrastructure and radiotherapy equipment, this first national survey has identified some weaknesses and developed some recommendations for the organization of PR.

Keywords:

Paediatric cancer, radiotherapy, Developing countries

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. - O’Leary M, Kraal M, Anderson JR, Reaman GH. Children’s Oncology Group. Progress in childhood cancer: 50 years of research collaboration, a report from the Children’s Oncology Group. Semin Oncol 2008;35(5):484-493. doi: 10.1053/j.seminoncol.2008.07.008.
  2. - Gupta S, Howard SC, Hunger SP, et al. Treating Childhood Cancer in Low- and Middle-Income Countries. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 7. Available from: https://www.ncbi.nlm.nih.gov/books/NBK343626/ doi: 10.1596/978-1-4648-0349-9_ch7.
  3. -Chirdan LB, Bode-Thomas F, Chirdan OO. Childhood cancers: challenges and strategies for management in developing countries. Afr J Paediatr Surg 2009;6(2):126-130. Doi: 10.4103/0189-6725.54783.
  4. - Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008;9(8): 721-729. Doi: 10.1016/S1470-2045(08)70194-3.
  5. - Howard SC, Marinoni M, Castillo L, et al. MISPHO Consortium Writing Committee. Improving outcomes for children with cancer in lowincome countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer 2007;48(3):364-369. Doi: 10.1002/pbc.21003.
  6. - Plan national de prévention et de Contrôle du Cancer 2010-2019. Available from : https://www.contrelecancer.ma/fr/le_pnpcc
  7. - Khiari H, Mallekh R, Hsairi M. Strategies of the Maghreb countries in the fight against cancer. Tunis Med. 2021 Jan; 99(1):148-157. PMC8636963
  8. - Registre des cancers de la région du Grand Casablanca Rapport d’incidence 2013-2017. Available from : https://contrelecancer.ma/site_media/uploaded_files/Registre_des_Cancers_de_la_Region_du_Grand_Casablanca_2013-2017.pdf
  9. - Plan national de prévention et de Contrôle du Cancer 2020-2029. Available from : https://www.contrelecancer.ma/site_media/uploaded_files/Plan_National_de_Prevention_et_de_Controle_du_Cancer_2020-2029_VF_MAJ.pdf
  10. - Carrie C, Mahe M-A. Organisation de la radiothérapie pédiatrique en France. Cancer Radiother 2009;13(6-7): 525–526. Doi : 10.1016/j.canrad.2009.06.019.
  11. - Hessissen L, Patte C, Martelli H, et al. African school of pediatric oncology initiative: implementation of a pediatric oncology diploma program to address critical workforce shortages in French-speaking Africa. J Glob Oncol, 2019 ;5 :1-12. Doi: 10.1200/JGO.19.00161.
  12. - Harif M, Hessissen L, Patte C. Les cancers de l'enfant en Afrique, réalisations et défis: expérience du Groupe franco-africain d'oncologie pédiatrique. Arch Pediatr. 2015; 22(5 Suppl 1):61-62. Doi : 10.1016/S0929-693X(15)30032-4
  13. - Demoor-Goldschmidt C, Claude L, et al. Organisation française de la radiothérapie pédiatrique : résultats d'une enquête du comité radiothérapie de la Société française des cancers de l'enfant (SFCE). Cancer Radiother. 2016;20(5):395-399. Doi.org/10.1016/j.canrad.2016.05.016
  14. - Anacak Y, Zubizarreta E, Zaghloul M, et al. The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study. Clin Oncol (R Coll Radiol). 2021;33(4):211-220. Doi: 10.1016/j.clon.2020.11.004.
  15. - Thenappan A, Halaweish I, Mody RJ, et al. Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer. Pediatr Blood Cancer 2017 ;64(2):254-258. Doi: 10.1002/pbc.26201.
  16. - Leseur J, Carrie C, Le Prisé É, et al. Radiothérapie conformationnelle par modulation d’intensité des tumeurs pédiatriques. Cancer Radiother 2009;13(6-7):536–42. Doi.org/10.1016/j.canrad.2009.07.006.
  17. - Habrand JL, Abdulkarim B, Roberti H. Radiotherapeutical innovations in pediatric solid tumors. Pediatr Blood Cancer 2004 ;43(6):622–628. Doi : 10.1002/pbc.20071.
  18. - Shuryak I, Ullrich RL, Sachs RK, Brenner DJ. The balance between initiation and promotion in radiation-induced murine carcinogenesis. Radiat Res 2010;174(3):357-366. Doi: 10.1667/RR2143.1.
  19. - Habrand JL, Bolle S, Datchary J, et al. La protonthérapie en radiothérapie pédiatrique. Cancer Radiother 2009;13(6-7):550–555. Doi: 10.1016/j.canrad.2009.07.001
  20. - Salminen E, Anacak Y, Laskar S, et al. Twinning partnerships through International Atomic Energy Agency (IAEA) to improve radiotherapy in common pediatric cancers in low- and mid-income countries. Radiother Oncol 2009;93(2):368-371. Doi: 10.1016/j.radonc.2009.08.018.
  21. - Hessissen L, Parkes J, Amayiri N, et al. SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settings. Pediatr Blood Cancer 2017;64 (Suppl. 5) : 1-15. Doi: 10.1002/pbc.26737.